Paper Details

  1. Home
  2. Paper Details

Well-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine.

Author: CohenRami, GrinshpoonAlexander, MargolisAnatoly, PonizovskyAlexander M, RoscaPaula

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Buprenorphine was found to be preferable for inpatient detoxification from heroin dependence, resulting in fewer side effects and improved well-being, self-efficacy, and social support compared to clonidine treatment.
Paper Details　
Original Abstract of the Article :
Previous studies comparing buprenorphine and clonidine provided little information about subjective factors associated with the effective management of opioid withdrawal. This study sought to compare detoxification programs using these medications with regard to side-effects and related distress, ge...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.addbeh.2006.01.014

データ提供：米国国立医学図書館（NLM）

Buprenorphine vs. Clonidine: Navigating the Desert of Opioid Withdrawal

[Opioid withdrawal] is a challenging and often difficult experience. This study delves into the desert of opioid withdrawal, comparing two different treatments: [buprenorphine] and [clonidine]. The researchers aimed to shed light on the subjective experiences associated with these medications, investigating not only the physical symptoms but also the emotional and psychological aspects of withdrawal. The results revealed that [buprenorphine] emerged as the more favorable choice, providing not only physical relief from withdrawal symptoms but also a sense of well-being, self-efficacy, and social support. This study emphasizes the importance of considering not only the physical but also the psychological aspects of opioid withdrawal, highlighting the potential benefits of buprenorphine for patients seeking to navigate this challenging terrain.

Buprenorphine: A More Supportive Oasis

This study highlights the potential benefits of buprenorphine in the management of opioid withdrawal. The researchers found that patients treated with buprenorphine experienced significantly fewer side-effects and reported higher levels of well-being, self-efficacy, and social support compared to those treated with clonidine. This suggests that buprenorphine may provide a more supportive and effective approach to navigating the challenges of opioid withdrawal.

Navigating the Desert of Opioid Withdrawal: Tips for Support

The desert of opioid withdrawal can be a lonely and challenging place, but there are ways to find support. This study highlights the potential benefits of buprenorphine in managing withdrawal symptoms and improving overall well-being. Seeking professional medical guidance and support from loved ones can also play a crucial role in navigating this difficult terrain.

Dr. Camel's Conclusion

Just as a traveler in the desert needs a reliable guide and a supportive companion, individuals navigating opioid withdrawal require a multifaceted approach that addresses both physical and psychological needs. This study suggests that buprenorphine may offer a more supportive and effective path through the desert of opioid withdrawal.

Date :
  1. Date Completed 2007-01-03
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

16524668

DOI: Digital Object Identifier

10.1016/j.addbeh.2006.01.014

Related Literature

Article Analysis
・Side Effects of clonidine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.